The Critical Role Of Data, Relationships, And Experience In Comparator Sourcing Success
Successfully sourcing commercial products for comparative studies often proves far more challenging than assumed.
Overcoming Current Clinical Trial Management Challenges
Clinical trial sponsors face many challenges in clinical trials – including how to mitigate risks that could cause delays and increase trial costs.
Planning And Conducting Trials Of The Latest Immunotherapies
In this webinar, INC Research/inVentiv Health experts discuss the factors that sponsors must take into account as they design and execute clinical trials in this space, beginning with a review of the immunotherapy landscape.
Are Delays In Clinical Trials Due To A Lack Of Experienced CRAs?
The webinar focuses issues and bottlenecks that contribute to delays that are outside of the CRA control.
New Tufts CSDD Study On End-To-End Site Identification Through Startup
This webinar covers the study assessing sponsor and CRO experience, practices and improvement areas associated with investigative site identification, feasibility, selection and study startup.
Spherix Announces Positive Interim Results In Phase 3 Trial Of Novel, Oral Compound For Type 2 Diabetes
Spherix Incorporated (NASDAQ CM: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced positive interim Phase 3 clinical results for the planned review of the NEET (Naturlose (D-tagatose) Efficacy Evaluation Trial) trial of D-tagatose in drug naïve patients.